Prospective, observational study to define precipitants and predictors of development of Acute-on-Chronic Liver Failure (ACLF) after surgical interventions, allowing to develop a risk stratification for elective procedures in cirrhotic patients. As well as identifying molecular mechanisms of post-interventional ACLF and thus preparing the ground for development of new therapeutic approaches.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Male or female adult (≥18 years) patient
* With or without liver cirrhosis (diagnosed either histologically or by a combination of clinical, laboratory and radiological signs)
* Or Non-cirrhotic portal hypertension
* Non-pregnant, non-lactating females
* Ability to understand the patient information and to personally sign and date the informed consent to participate in the study
* The patient is co-operative and available for the entire study
* Provided written informed consent
* Indication for surgical intervention
Exclusion Criteria:
* Pregnant or lactating females
* Patients undergoing surgery as form of palliative cancer therapy
* Presence or history of severe extra-hepatic diseases
* HIV-positive patients
* Previous liver or other transplantation
* Patients with acute or subacute liver failure without underlying cirrhosis
* Patients who decline to participate
* Physician´s denial (e.g. the investigator considers that the patient will not follow the protocol scheduled)
Primary outcome measure(s)
Episodes of Acute-on-Chronic Liver Failure (ACLF) — 90 days Development of ACLF after surgery
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.